These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10475393)

  • 21. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H; Ohta M; Tanaka H; Sakaguchi M; Fujii Y; Miyoshi S; Matsuda H
    J Surg Oncol; 2002 Dec; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic molecular markers in non-small cell lung cancer.
    Nikliński J; Niklińska W; Laudanski J; Chyczewska E; Chyczewski L
    Lung Cancer; 2001 Dec; 34 Suppl 2():S53-8. PubMed ID: 11720742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
    Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
    Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological prognostic factors for early stage completely resected non-small cell lung cancer.
    Cagini L; Monacelli M; Giustozzi G; Moggi L; Bellezza G; Sidoni A; Bucciarelli E; Darwish S; Ludovini V; Pistola L; Gregorc V; Tonato M
    J Surg Oncol; 2000 May; 74(1):53-60. PubMed ID: 10861611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
    Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
    Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E-cadherin expression in surgically-resected non-small cell lung cancers--a clinicopathological study.
    Lee YC; Wu CT; Chen CS; Chang YL
    Thorac Cardiovasc Surg; 2000 Oct; 48(5):294-9. PubMed ID: 11100763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of expression of p53 oncoprotein in primary (stage I-IIIa) non-small cell lung cancer.
    Tan DF; Li Q; Rammath N; Beck A; Wiseman S; Anderson T; al-Salameh A; Brooks J; Bepler G
    Anticancer Res; 2003; 23(2C):1665-72. PubMed ID: 12820438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of micropapillary pattern in lung adenocarcinoma and expression of apoptosis-related markers: caspase-3, bcl-2, and p53.
    Cakir E; Yilmaz A; Demirag F; Oguztuzun S; Sahin S; Yazici UE; Aydin M
    APMIS; 2011 Sep; 119(9):574-580. PubMed ID: 21851414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer.
    Gregorc V; Darwish S; Ludovini V; Pistola L; De Angelis V; Mihaylova Z; Bellezza G; Sidoni A; Cavaliere A; Bucciarelli E; Massaro G; Tonato M
    Lung Cancer; 2003 Dec; 42(3):275-81. PubMed ID: 14644514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
    Gharabaghi MA
    Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
    Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
    BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic relevance of altered pRb and p53 protein expression in surgically treated non-small cell lung cancer patients.
    Dworakowska D; Jassem E; Jassem J; Wiedorn KH; Boltze C; Karmoliński A; Dworakowski R; Skokowski J; Jaśkiewicz K; Bosse A; Czestochowska E
    Oncology; 2004; 67(1):60-6. PubMed ID: 15459497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of P53 protein is not associated with a poor prognosis in non-small-cell lung cancer.
    Passlick B; Izbicki JR; Häussinger K; Thetter O; Pantel K
    J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1205-11. PubMed ID: 7776684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations.
    Peretti U; Ferrara R; Pilotto S; Kinspergher S; Caccese M; Santo A; Brunelli M; Caliò A; Carbognin L; Sperduti I; Garassino M; Chilosi M; Scarpa A; Tortora G; Bria E
    Respir Res; 2016 Aug; 17(1):105. PubMed ID: 27561692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological features and preoperative evaluation of mediastinal nodal status in non-small cell lung cancer.
    Tanaka F; Yanagihara K; Otake Y; Li M; Miyahara R; Wada H; Ito H
    Ann Thorac Surg; 2000 Dec; 70(6):1832-8. PubMed ID: 11156080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.